EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION Patent applications |
Patent application number | Title | Published |
20160098351 | DEVICE AND METHOD FOR INTEGRATED DATA MANAGEMENT FOR NONVOLATILE BUFFER CACHE AND NONVOLATILE STORAGE - An integrated nonvolatile memory control subsystem and method are disclosed. The integrated nonvolatile memory control subsystem includes a nonvolatile buffer cache, a nonvolatile journal area, nonvolatile storage, and an integrated memory control unit. The integrated memory control unit performs a read operation, a write operation, a commit operation and a checkpoint operation on the cache blocks of the nonvolatile buffer cache and the journal blocks of the nonvolatile journal area. The integrated memory control unit sets each of data blocks of the nonvolatile storage as one among valid state, erasable state and invalid state, depending on being cached or not, being journaled or not, and being a clean cache or not, so as to maintain an authentic original up-to-date consistent data within any one of the nonvolatile buffer cache, the nonvolatile journal area and the nonvolatile storage. | 04-07-2016 |
20160083344 | COMPOUND BASED ON CYANINE SCAFFOLD FOR DIAGNOSIS SEPSIS BY SELECTIVELY DETECT GLUTATHIONE - The present invention relates to a compound based on cyanine scaffold for diagnosing sepsis by selectively detecting glutathione. The compound based on cyanine scaffold according to the present invention has the advantages of maintaining its structure in intracellular environment and of reacting selectively to glutathione only among many amino acids containing thiol group (R—SH) such as cysteine, homocysteine, and glutathione, to produce changes in absorption or fluorescence spectrum, making the compound useful for the detection of in vivo glutathione in biosamples and also for the diagnosis of sepsis characteristically displaying the changes of glutathione concentration. | 03-24-2016 |
20160042684 | DISPLAY DEVICE, SCAN DRIVER, AND METHOD OF MANUFACTURING THE SAME - Provided are a display device, a scan driver, and a method of manufacturing the same. A scan driver includes: a level shifter configured to output a power and a signal, and a scan signal generating circuit configured to generate a scan signal based on the power and the signal supplied from the level shifter, the scan signal generating circuit including a buffer configured to transmit a clock signal to a stage of a shift register, the buffer including two inverters, one of the two inverters being included in a multi-buffer. | 02-11-2016 |
20140371244 | METHOD FOR TREATING PROSTATE CANCER BY USE OF PHARMACEUTICAL COMPOSITION CONTAINING A3 ADENOSINE RECEPTOR AGONIST - The present invention relates to a method by use of a pharmaceutical composition for preventing or treating inflammatory disease, colorectal cancer and prostate cancer, which contains an A | 12-18-2014 |
20140329331 | NOVEL CYANINE DERIVATIVES HAVING MESO-REACTIVE FUNCTIONAL GROUP AT POLYMETHINE CHAIN AND PREPARATION METHOD THEREOF - The present invention relates to a novel cyanne derivative having a meso-reaction functional group in a polymethine chain, and a preparation method thereof, and the cyanine derivative having the reaction functional group substituted at the meso site may be suitable for mass production thanks to a very simple synthesis method, have a very fast reaction rate because while a related art reagent for detection of nerve agents undergoes two steps of reactions, the cyanine derivative of the present invention undergoes only one step of reaction, have very excellent sensitivity, and be useful as an acid pH-activated ratiometric NIR probe because it is able to be activated in an acidic pH and is usable in an aqueous environment. | 11-06-2014 |
20140297918 | BUFFER CACHE APPARATUS, JOURNALING FILE SYSTEM AND JOURNALING METHOD FOR INCORPORATING JOURNALING FEATURES WITHIN NON-VOLATILE BUFFER CACHE - Disclosed herein are a buffer cache apparatus, a journaling file system, and a journaling method capable of incorporating journaling features based on nonvolatile memory. The buffer cache apparatus provides a data buffering function between a central processing unit (CPU) and storage. The buffer cache apparatus includes a plurality of cache blocks and a journal management unit. The plurality of cache blocks are configured as volatile or nonvolatile memory devices. The journal management unit maintains states of freezing for write-protecting dirty up-to-date cache blocks among the plurality of cache blocks. | 10-02-2014 |
20140296333 | COMPOSITION OF THE TREATMENT OF VASCULAR DISEASES OR KCa3.1 CHANNEL-MEDIATED DISEASES COMPRISING MODAFINIL OR DERIVATIVES THEREOF - The present invention relates to modafinil or derivatives thereof as a medicine for the treatment of vascular diseases or KCa3.1 channel (Ca activated K channel) mediated diseases and a novel use of the same. More specifically, the present invention relates to a pharmaceutical composition for the prevention or treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or a derivative of modafinil, or pharmaceutically acceptable salts thereof which relax blood vessels and inhibit KCa3.1 channel currents by increasing intracellular cAMP, a method for treating vascular diseases or KCa3.1 channel-mediated diseases using the composition and a health functional food composition for the prevention or improvement of vascular diseases or the KCa3.1 channel-mediated diseases comprising modafinil or a modafinil derivative compound, or sitologically acceptable salts thereof. | 10-02-2014 |
20140243218 | COMPOSITION FOR DIAGNOSING OVARIAN CANCER METASTASIS USING CPG METHYLATION STATUS OF GENE PROMOTER AND USE THEREOF - The present invention relates to a composition, a kit and a method for diagnosing ovarian cancer metastasis or predicting the risk of metastasis by detecting methylation levels at CpG sites of one or more gene promoters selected from the group consisting of AGR2 (anterior gradient 2), CA9 (carbonic adj anhydrase 9), GABRP (gamma-aminobutyric acid receptor pi subunit), IFITM1 (interferon-induced transmembrane 1) and MUC13 (mucin 13). | 08-28-2014 |
20140189449 | METHOD AND SYSTEM FOR CHECKING SOFTWARE - A method and a system that checks software and includes a hooking module that collects process control block (PCB) information corresponding to each process on a kernel by being executed at the time of booting a system. In addition, the system includes a safety service module that searches and defends the defects of the process by being inserted into a memory region of the process based on the collected PCB information. | 07-03-2014 |
20140174514 | METAL OXIDE-CARBONACEOUS HYBRID THIN FILM AND PREPARING METHOD THEREOF - The present disclosure relates to a metal oxide-carbonaceous hybrid thin film, a preparing method of the metal oxide-carbonaceous hybrid thin film, and a dye-sensitized solar cell using a photoelectrode including the metal oxide-carbonaceous hybrid thin film. | 06-26-2014 |
20140128418 | PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREVENTING AND TREATING OSTEOPOROSIS CONTAINING SAME - The present invention provides a pyrazole derivative compound and a pharmaceutically acceptable salt thereof. The compound of the invention is remarkably effective for preventing and treating osteoporosis. | 05-08-2014 |
20140088152 | COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES, CONTAINING PYRAZOLE DERIVATIVE - The present invention provides a composition comprising a pyrazole derivative compound and a pharmaceutically acceptable salt thereof. The composition is remarkably effective for preventing and treating cardiovascular diseases. | 03-27-2014 |
20140066404 | PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS CONTAINING SAME - The present invention provides pyrazole derivative compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of preventing and treating osteoporosis. | 03-06-2014 |
20140050298 | INTRA-ORAL X-RAY IMAGING DEVICE EQUIPPED WITH CAMERA - Provided is an intraoral X-ray imaging apparatus having a camera, including: a frame; an X-ray irradiator which is installed to be supported by the frame and of which the one end portion is inserted into the oral cavity and which irradiates X-ray through an X-ray irradiation hole formed on the one end portion inserted into the oral cavity; a camera unit which is installed at the one end portion of the X-ray irradiator to image an interior of the oral cavity; a monitor unit which is connected to a camera unit to output the image captured by the camera unit; and an X-ray detector which is arranged to be separated from the X-ray irradiator in the frame so as to detect the X-ray irradiated from the X-ray irradiator outside the oral cavity. In the intraoral X-ray imaging apparatus having a camera, since the X-ray irradiator is located inside the oral cavity, it is possible to obtain an image having a high quality with a low X-ray dose and to avoid confusion in image diagnosis by removing a ghost image. In addition, since the imaging object tooth can be accurately identified inside the oral cavity, the X-ray can be irradiated on only the imaging object tooth, so that it is possible to minimize a radiation exposure dose applied to the head of a patient. | 02-20-2014 |
20140029719 | INTRA-ORAL X-RAY IMAGING DEVICE FOR DETECTING X-RAYS FROM OUTSIDE THE ORAL CAVITY - Provided is an intraoral X-ray imaging apparatus for detecting X-ray outside an oral cavity, including: a frame; an X-ray irradiator which is installed to be supported by the frame and of which the one end portion is inserted into the oral cavity and which irradiates X-ray through an X-ray irradiation hole formed on the one end portion inserted into the oral cavity; and an X-ray detector which is arranged to be separated from the X-ray irradiator in the frame so as to detect the X-ray irradiated from the X-ray irradiator outside the oral cavity and which is movably installed so as to adjust a distance to the X-ray irradiator. In the X-ray imaging apparatus and an imaging method using the X-ray imaging apparatus, since the X-ray irradiator is located inside the oral cavity, it is possible to obtain an image having a high quality with a low X-ray dose and to avoid confusion in image diagnosis by removing a ghost image. In addition, since a distance between the X-ray irradiator and the X-ray detector is minimized, it is possible to obtain images of portions of a tooth with constant magnification and to obtain accurate images without distortion. | 01-30-2014 |
20130295060 | METHOD FOR CULTURING CARDIAC PROGENITOR CELLS AND USE OF CARDIAC PROGENITOR CELLS - Disclosed is a method for culturing myocardium-resident cardiac progenitor cells, comprising: embedding myocardial fragments into hydrogel; culturing the myocardial fragment into hydrogel; degrading only the hydrogel to recover cardiac progenitor cells grown out of the myocardial fragment to the hydrogel; and amplifying the cardiac progenitor cells in vitro. Also, the cardiac progenitor cells, a method for differentiating the same, and the use thereof as cell therapeutic agent for heart diseases are provided. In addition to possessing the potential to differentiate into cardiomyocytes, osteoblasts, adipocytes, chondrocytes, vascular endothelial cells, smooth muscle cells, neural cells, and skeletal muscle cells, the myocardium-resident cardiac progenitor cells can spontaneously differentiate into cardiomyocytes even in the absence of a special differentiation inducing agent. Thus, the cardiac progenitor cells can be used to produce bio-active medicines such as cell therapeutics and tissue engineering therapeutics with high industrial applicability. | 11-07-2013 |
20130273458 | ELECTROCATALYST FOR OXYGEN REDUCTION INCLUDING SILVER/SILVER HALIDE COMPOSITE, FUEL CELL INCLUDING THE SAME, AND PREPARING METHOD OF THE SAME - The present disclosure relates to an electrocatalyst for oxygen reduction including a silver/silver halide composite, a fuel cell including the electrocatalyst for oxygen reduction, and a method for preparing the electrocatalyst for oxygen reduction. | 10-17-2013 |
20130265814 | MAGNETIC RAMDOM ACCESS MEMORY - A magnetic random access memory includes multiple gate lines that are divided into a first gate line group and a second gate line group and arranged to be parallel to one another; multiple magnetic random access memory cells that are bonded to the gate lines in a direction intersected with the gate lines, respectively; multiple source lines that are bonded to one ends of switching devices included in the magnetic random access memory cells and arranged to be parallel to one another; and multiple bit lines that are bonded to one ends of magnetic tunnel junction devices included in the magnetic random access memory cells and arranged to be parallel to one another. | 10-10-2013 |
20130245066 | 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors - 2-pyridyl-substituted imidazoles which are used advantageously in the treatment of diseases mediated by ALK 5 or ALK 4 receptor or both. | 09-19-2013 |
20130224257 | METHOD FOR PREPARING MICROSPHERES AND MICROSPHERES PRODUCED THEREBY - The present invention relates to a method for preparing microsphere and microspheres produced thereby. The method comprises: mixing a water-insoluble organic solvent with a dispersion solvent; mixing a polymer compound, a drug and a water-insoluble organic solvent to prepare a dispersed phase; mixing the dispersed phase with the dispersion solvent mixed with the water-insoluble organic solvent to prepare an emulsion; and adding a base or an acid to the prepared emulsion. With the method, it is possible to prepare a drug-containing polymeric microsphere cost-effectively and conveniently. | 08-29-2013 |
20130161570 | MANGANESE OXIDE/GRAPHENE NANOCOMPOSITE AND PRODUCING METHOD OF THE SAME - The present disclosure provides a method for producing a manganese oxide/graphene nanocomposite including synthesizing a manganese oxide/graphene nanocomposite through liquid phase reaction at a room temperature, a manganese oxide/graphene nanocomposite produced by the method, and an electrode material and a super-capacitor electrode including the manganese oxide/graphene nanocomposite. | 06-27-2013 |
20130137181 | Ethanol-Resistant Yeast Gene, and Use Thereof - The present invention relates to a gene associated with ethanol tolerance, and yeast strains and uses using the same. The yeast strain of this invention may growth under the condition not only with high-concentration ethanol, preferably 6-15% ethanol, but also in high osmotic pressure, preferably 30-40% glucose or sucrose. The present inventors developed yeast strains resistant to high-concentration glucose and ethanol, suggesting that they would be valuably applied to much effective ethanol production, and also be utilized as a superbacteria having tolerance to various stresses for ethanol production with high efficiency. | 05-30-2013 |
20130096880 | SYSTEM TEST METHOD - Disclosed is a test system and method that is configured to identify a position of a process control block, access the position of the process control block, and monitor performance factors related to the process control block. | 04-18-2013 |
20130096078 | NEW KANAMYCIN COMPOUND, KANAMYCIN-PRODUCING STREPTOMYCES SPECIES BACTERIUM, AND METHOD OF PRODUCING KANAMYCIN - Vectors expressing kanA-kanB-kanK and other kanamycin production-related genes, | 04-18-2013 |
20130043129 | GAS SENSOR AND PREPARING METHOD OF THE SAME - The present disclosure relates to a gas sensor including a nanopore electrode and a fluorine compound coated on the nanopore electrode, and also relates to a preparing method of the gas sensor. | 02-21-2013 |
20130040999 | NEW COMPOUNDS FOR ALLEVIATION, PREVENTION OR TREATMENT OF OSTEOPOROSIS, THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - The present invention provides novel compounds of Chemical Formula I, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof, a preparation thereof and a composition for the alleviation, prevention or treatment of osteoporosis, comprising thereof in an effective amount, and a method for alleviating, preventing or treating osteoporosis. | 02-14-2013 |
20130018194 | OCTAHYDROBINAPHTHOL DERIVATIVE FOR L/D OPTICAL CONVERSION AND OPTICAL RESOLUTIONAANM Kim; Kwan-MookAACI SeoulAACO KRAAGP Kim; Kwan-Mook Seoul KR - This invention relates to octahydro-binaphthol derivatives, which can recognize amino acids and amino alcohols enantioselectively and transform L-amino acids into D-amino acids and optically resolve amino acids or amino alcohol with high efficiency. | 01-17-2013 |
20120330013 | PREPARATION METHOD OF MLN4924 AS AN E1 ACTIVATING INHIBITOR - The present invention relates to a method for preparation of MLN4924 as an E1 activating inhibitor, and more specifically, to a method for efficient and stereoselective preparation of MLN4924 by means of key steps involving stereoselective reduction of cyclopentenone with isopropylidene, regioselective cleavage of isopropylidene moiety, and synthesis of cyclic sulfate. | 12-27-2012 |
20120328617 | METHOD FOR INHIBITING ANGIOGENESIS - The present invention relates to a method for inhibiting angiogenesis using a peroxiredoxin II (Prx II) inhibitor, and a method for preparing angiogenesis-inhibiting medicines using Prx II inhibitor. According to the present invention, the inhibitor of Prx II gene expression or Prx II protein activity increases oxidative inactivation of VEGF receptor tyrosine kinase (RTK) to reduce VEGF signaling, thereby screening a novel angiogenesis inhibitor. Therefore, the method of the present invention can be used for the prevention or treatment of various diseases, ailments, and conditions related to angiogenesis. | 12-27-2012 |
20120322815 | PHARMACEUTICAL COMPOSITION CONTAINING A3 ADENOSINE RECEPTOR AGONIST - The present invention relates to a pharmaceutical composition for preventing or treating inflammatory disease, colorectal cancer and prostate cancer, which contains an A | 12-20-2012 |
20120308568 | PHARMACEUTICAL COMPOSITION FOR INHIBITING ABNORMAL PROLIFERATION OF CELLS - The present invention relates to a pharmaceutical composition for preventing or treating diseases related to abnormal proliferation of cells, comprising a cytoplasmic heat shock protein (Hsp)60 kDa inhibitor as an active ingredient, and to a screening method and a kit using the composition. According to the present invention, substances which inhibit expression of cytoplasmic Hsp 60 genes or inhibit activity of cytoplasmic Hsp 60 or inhibit binding between cytoplasmic Hsp 60 and IKK protein prevent interaction between cytoplasmic Hsp 60 and IKK complexes to make NF-κB path inactive, and thus induce apoptosis. Therefore, the substances can be valuably used in preventing or treating diseases related to abnormal proliferation of cells, such as cancer, inflammatory diseases or hyperproliferative vascular diseases. | 12-06-2012 |
20120232117 | PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS CONTAINING SAME - The present invention provides pyrazole derivative compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of preventing and treating osteoporosis. | 09-13-2012 |
20120220550 | PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS CONTAINING SAME - The present invention provides pyrazole derivative compounds and pharmaceutically acceptable salts thereof. The compounds of the present invention have an excellent effect of preventing and treating osteoporosis. | 08-30-2012 |
20120219944 | MYH14 AS CAUSATIVE GENE RESPONSIBLE FOR COMPLEX PHENOTYPE OF PERIPHERAL NEUROPATHY, MYOPATHY, HEARING LOSS AND HOARSENESS, AND DIAGNOSTIC METHOD AND KIT FOR THE COMPLEX PHENOTYPE USING THE SAME - The present invention newly identified a missense mutation in the MYH14 gene as a cause responsible for a complex phenotype of peripheral neuropathy, myopathy, hearing loss, and hoarseness. Further, the present invention provides a method for diagnosing inherited neuromuscular disorders showing a complex phenotype of peripheral neuropathy, myopathy, hearing loss, and hoarseness via detection of the mutated MYH14 gene or the protein encoded thereby, and a diagnostic kit therefor. According to the present invention, simple examination of the gene allows early diagnosis of inherited neuromuscular disorders showing the complex phenotype of peripheral neuropathy, myopathy, hearing loss, and hoarseness, which shows high inheritance and is caused by a single gene defect, and accurate diagnosis of the disease makes it possible to tailor therapy. | 08-30-2012 |
20120190724 | NOVEL ANTICANCER-AIDING COMPOUND, METHOD FOR PREPARING THE SAME, ANTICANCER-AIDING COMPOSITION CONTAINING THE SAME AND METHOD FOR REDUCING ANTICANCER DRUG RESISTANCE USING THE SAME - The present invention provides a novel xanthone derivative compound or a pharmaceutically acceptable salt thereof. The compound is useful as a chemosensitizer that reduces anticancer drug resistance. | 07-26-2012 |
20120186643 | COMPOUND SEMICONDUCTOR SOLAR CELLS AND METHODS OF FABRICATING THE SAME - Provided is a tandem-type compound semiconductor solar cell. The solar cell includes a transparent substrate and a plurality of solar cell layers provided on at least one surface of the transparent substrate. The plurality of solar cell layers respectively includes window layer and light absorbing layer. The light absorbing layer includes Cu(InGa)Se | 07-26-2012 |
20120176402 | METHOD OF DETECTING COLLISIONS IN GRAPHICS PROCESSING UNIT - The present invention relates to a method of detecting collisions on a Graphics Processing Unit (GPU). Each collision detection object O | 07-12-2012 |
20120131595 | PARALLEL COLLISION DETECTION METHOD USING LOAD BALANCING AND PARALLEL DISTANCE COMPUTATION METHOD USING LOAD BALANCING - Disclosed herein is a parallel collision detection method using load balancing in order to detect collision between two objects of a polygon soup. The parallel collision detection method is processed in parallel using a plurality of threads. The parallel collision detection method includes traversing a Bounding Volume Traversal Tree (BVTT) using Bounding Volume Hierarchies (BVHs) related to the polygon soup in a depth first search manner or a width first search manner; recursively traversing the children node of an internal node (a parent node) when a currently traversed node is the internal node and two Boundary Volumes (BVs) in the corresponding node overlap, and stopping to traverse the node when the currently traversed node is the internal node and two Boundary Volumes (BVs) do not overlap; and storing collision primitives in a leaf node when the currently traversed node is the leaf node and collision primitives in the leaf node overlap. | 05-24-2012 |
20120098605 | FEED-FORWARD RING OSCILLATOR - Disclosed herein is a feed-forward ring oscillator. The feed-forward ring oscillator includes a plurality of delay cells for receiving a first differential input signal pair and a second differential input signal pair, and outputting a differential output signal pair. The delay cells are connected in a ring shape. Each of the delay cells receives a differential output signal pair of a delay cell of a previous stage as a first differential input signal pair and receives a differential output signal pair of a delay cell of a stage before the previous stage as a second differential input signal pair. Each of the delay cells comprises multiple independent gate field-effect transistors. | 04-26-2012 |
20120070515 | Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder - The present invention relates to a composition comprising an extract of | 03-22-2012 |
20120025340 | VERTICAL SILICON PHOTOMULTIPLER WITH SUPERIOR QUANTUM EFFICIENCY AT OPTICAL WAVELENGTHS - The vertical silicon photomultiplier according to the present invention includes a trench electrode and a PN-junction layer perpendicular to the trench electrode forms and can maximize the quantum efficiency at optical wavelengths, 200˜900 nm in such a way that: it generates electric fields horizontal thereto, by applying a reverse bias voltage to between the trench electrode and the PN junction layer, so that, although ultraviolet light does not reach the PN-junction layer but is incident on the surface, electron-hole pairs can be produced by the horizontally generated electric fields although and an avalanche breakdown can be thus generated, and it allows ultraviolet light, capable of being transmitted to a relatively deep depth, to react with the PN-junction layer. | 02-02-2012 |
20110319408 | Methods of Treating Fibrosis, Cancer and Vascular Injuries - This invention relates to use of inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4) in treating, preventing, or reducing fibrosis, cancer, and vascular injuries. | 12-29-2011 |
20110319406 | 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS - This invention relates to 2-pyridyl substituted imidazoles which are inhibitors of the transforming growth factor-β (TGF-β) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors. | 12-29-2011 |
20110293599 | METHOD FOR MODULATING MUSCLE DIFFERENTIATION OR REGENERATION - Present invention relates to method for promoting or inhibiting muscle differentiation or regeneration using an enhancer or an inhibitor capable of modulating the binding of TAZ polypeptide with MyoD polypeptide; method for screening a substance capable of up- or down-regulating muscle differentiation or regeneration by use of interaction between TAZ polypeptide and MyoD polypeptide; an isolated peptide consisting of an amino acid sequence of SEQ ID NO. 2 which binds to and activates the MyoD polypeptide; a polynucleotide encoding the isolated peptide; and a pharmaceutical composition comprising the isolated peptide or the polynucleotide. | 12-01-2011 |
20110219010 | METHOD AND APPARATUS FOR PACKET CLASSIFICATION USING BLOOM FILTER - The present disclosure provides an apparatus and method for packet classification using a Bloom filter and includes determining a matching length of how long each field value of one or more fields in an input packet coincides with a field value of the corresponding field stored in a rule set by performing a field-by-field search on the fields in the input packet, and generating a tuple list made up of a combination of one or more of the matching length for the respective fields; selecting particular tuples existing in the rule set from the tuple list; filtering each of the selected tuples by using the Bloom filter; and searching for a best matching rule as a search pool exclusively within the tuples with the positive result of the filtering. According to the present disclosure, the object tuples to search can be substantially relieved to improve the searching performance. | 09-08-2011 |
20110217341 | METHOD FOR PREPARING MICROSPHERES AND MICROSPHERES PRODUCED THEREBY - The present invention relates to a method for preparing microspheres and microspheres prepared thereby, more particularly to a method for preparing a polymeric microsphere, including preparing an emulsion including a polymer compound, a drug, a water-insoluble organic solvent and a dispersion solvent and adding to the prepared emulsion a base or an acid to remove the water-insoluble organic solvent from the emulsion, a polymeric microsphere prepared thereby, and a composition for drug delivery including the microsphere. According to the present invention, a drug-containing polymer microsphere may be prepared quickly and simply without the solvent evaporation or solvent extraction process, thereby reducing water consumption and minimizing wastewater generation. | 09-08-2011 |
20110092796 | METHOD FOR DIAGNOSING CMT1A AND CMT2A BY MRI - Disclosed is a method for diagnosing Charcot-Marie-Tooth (CMT) disease. More specifically, disclosed is a method for diagnosing a subtype of Charcot-Marie-Tooth disease type 1, (i.e., CMT1A) and a subtype of the disease type 2 (i.e., CMT2A) by evaluating fatty infiltration behaviors in respective compartments of proximal lower extremity muscles via comparison and analysis of MRI on the proximal lower extremities. Further disclosed is a method for diagnosing CMT1A and CMT2A, by analyzing fatty infiltration levels between respective compartments by MRI examination on distal lower extremity muscles. | 04-21-2011 |
20100284405 | METHOD AND APPARATUS FOR SEARCHING IP ADDRESS - The present disclosure provides IP address lookup method and apparatus. In one embodiment of the disclosure, an IP address lookup apparatus stores node information generated for a binary search-on-levels architecture in a universal multi-hashing table prior to searching with an advance filtering by a universal Bloom filter minimizing the number of accesses to the universal multi-hashing table before executing the IP address lookup. | 11-11-2010 |
20100237226 | OPTICAL MODULE, WHICH IS ABLE TO FIRE A BEAM - An optical module is disclosed. The optical module includes: (1) a mirror part for controlling its reflection angle in an analog method; (2) an aperture for controlling an amount of light incident to the mirror part, the aperture being installed facing the mirror part; (3) a detector for detecting an optical signal from a light transmitted from the mirror part; (4) a beam emitter for emitting a beam, the beam emitter being adjacently installed to the optical signal detector; and (5) a controller for controlling the mirror part so as to locate an object, detected by the optical signal detector, at the center portion of the optical signal detector, and for controlling the beam emitter and the mirror part so as to emit a beam from the beam emitter to the object detected by the optical signal detector. The optical module can observe an object both in a wide field of view (FOV) and in detail, effectively track a rapidly moving object, and emit a beam to the object. | 09-23-2010 |
20100168034 | PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY - The present invention provides a peptide having cell membrane penetrating activity, a transmembrane carrier comprising the peptide having cell membrane penetrating activity as an effective component, a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance, a transfection kit comprising the peptide having cell membrane penetrating activity and the target substance, use of the peptide having cell membrane penetrating activity for the manufacture of a transmembrane complex, use of the transmembrane complex for the manufacture of a medicament, and a method for delivering a target substance into cell interior which comprises administrating to a subject with a transmembrane complex consisting of the peptide having cell membrane penetrating activity combined with a target substance to induce transduction of the transmembrane complex into cell interior. The peptide having cell membrane penetrating activity of the present invention has a prominent penetrating efficiency as compared with the activities of prior TAT-derived peptides and so the peptide has applications on intracellular delivery in various research fields as well as on therapeutics of specific diseases where targeting of drugs is required at high efficiency. Accordingly, the peptide having cell membrane penetrating activity, the transmembrane complex consisting of the peptide combined with a target substance and the method for delivering a target substance into cell interior using the transmembrane complex of the present invention are very useful as drug delivery systems. | 07-01-2010 |
20100103730 | MAGNETIC MEMORY CELL - The present invention relates to a magnetic memory cell, which controls the magnetization direction of the free magnetic layer of a Magnetic Tunnel Junction (MTJ) device using a spin torque transfer, and enables the implementation of a magnetic logic circuit, in which memory and logic circuit functions are integrated. The magnetic memory cell includes an MTJ device ( | 04-29-2010 |
20100023727 | IP ADDRESS LOOKUP METHOD AND APPARATUS BY USING BLOOM FILTER AND MULTI-HASHING ARCHITECTURE - The present invention relates to an IF address lookup apparatus using a Bloom filter and a multi-hashing architecture that includes a buffering means that outputs a prefix of an inputted address having the number of bits reduced by one bit whenever a control signal is received at the time of outputting the prefix of the inputted address; a hashing hardware that generates a plurality of hashing indexes by hashing the prefix (hereinafter, referred to as “output prefix”) outputted from the buffering means; a Bloom filter that determines whether or not the output prefix is an entry of the hash table by using the plurality of hashing indexes; and a processor that includes the hash table and an overflow table and outputs a prefix that matches the output prefix by searching entries of locations of the hash table indicated by the plurality of hashing indexes and entries stored in the overflow table when a Bloom filter's determination result is positive and outputs the control signal to the buffering means when the matched prefix is not provided or the Bloom filter's determination result is negative. | 01-28-2010 |
20090324583 | METHODS FOR INDUCING THE DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS INTO MEGAKARYOCYTES AND PLATELETS, AND GENE CONTROLLING THE DIFFERENTIATION - The present invention relates to a method for inducing the differentiation of CD34+ hematopoietic stem cells into megakaryocytes and platelets, more particularly, a method for inducing the differentiation of CD34+ hematopoietic stem cells into megakaryocytes and platelets comprising the steps of coculturing CD34+ hematopoietic stem cells with stromal cells and adding the compound of Formula 1. Further, the present invention relates to a composition for detecting the differentiation of hematopoietic stem cells into megakaryocytes and platelets, comprising an agent measuring expression level of a gene that is selected from the group consisting of KLF2 (Kiruppel-like factor2), LOC138255 (OTTHUMP00000021439), GDF15 (growth differentiation factor 15) and INHBE (inhibin, betaE), a kit comprising the composition, a method for detecting the differentiation into megakaryocytes and platelets by using the marker genes, a method for regulating the differentiation into megakaryocytes and platelets, and a method for screening a candidate compound that regulates the differentiation into megakaryocytes and platelets. | 12-31-2009 |
20090296627 | APPARATUS AND METHOD FOR SELECTING RELAY STATION MODE IN WIRELESS COMMUNICATION SYSTEM - Method and apparatus for selecting an RS mode in a BWA communication system are provided. In a method for a BS to select an RS mode in a BWA communication system, bidding prices are received from a set of RSs covered by the BS. The winner RS of at least one or more auctions is determined on the basis of the bidding values and the interference information of the RS set. The winner RS is set to operate in an active mode. | 12-03-2009 |
20090286223 | Methods And Kits For In Situ Measurement of Enzyme Activity and Amount Using Single Measurement System - Disclosed are methods and kits for measuring in situ the activity and amount of an enzyme in a sample using a single measurement system. The method includes the steps of: (a) contacting a sample to a capturing agent having the capacity to bind to the enzyme to be analyzed and immobilized on a solid matrix; (b) measuring the activity of the enzyme captured by the capturing agent; (c) contacting a detection antibody specific to the enzyme captured by the capturing agent; and (d) detecting an antigen-antibody complex formed in the step (c). There is no need for separate measurement system to measure the activity and amount of an enzyme, as well as the above methods and kits permit to measure the precise activity and amount of an enzyme simultaneously because the measurement of enzyme activity and amount is carried out in a single and same measurement system as to the same sample in almost simultaneous manner. | 11-19-2009 |
20090023931 | ALANINE RACEMASE CHIRAL BINAPHTHOL DERIVATIVE WITH POWERFUL HYDROGEN BOND DONOR, AND OPTICAL RESOLUTION AND OPTICAL TRANSFORMATION METHODS USING THE SAME - Disclosed is an alanine racemase chiral binaphthol derivative having the ability to recognize amino alcohols selectively on the basis of chirality and transform amino acids from an L-form into a D-form. Methods for the optical resolution of amino acid or amino alcohol and for the optical transformation of D- and L-forms of amino acids using the binaphthol derivative are also provided. | 01-22-2009 |
20090004228 | BORON COMPOUND-LAYERED DOUBLE HYDROXIDE NANOHYBRID, METHOD OF PREPARING THE BORON COMPOUND-LDH NANOHYBRID, AND PHARMACEUTICAL COMPOSITION COMPRISING THE BORON COMPOUND-LDH NANOHYBRID - Provided are a boron compound-layered double hydroxide (LDH) nanohybrid in which a boron compound for boron neutron capture therapy is intercalated in between layers of LDH, a method of preparing the boron compound-LDH nanohybrid, and a pharmaceutical composition including the boron compound-LDH nanohybrid, which can be used in boron neutron capture therapy. | 01-01-2009 |
20080319012 | 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors - 2-pyridyl-substituted imidazoles which are used advantageously in the treatment of diseases mediated by ALK 5 or ALK 4 receptor or both. | 12-25-2008 |
20080270996 | APPARATUS AND METHOD FOR AUTOMATICALLY EXTRACTING INTERFACE OF EMBEDDED SOFTWARE - Provided is an apparatus and method for automatically extracting an interface of embedded software. The method defines an interface of embedded software as a test item for test of the interface of the embedded software, and generates an interface symbol corresponding to the defined test item. The location of the interface symbol is determined, and a test case is generated based on the interface symbol and its location in the software. Embodiments of the invention thus facilitate the testing of software at interfaces between layers in the software. | 10-30-2008 |
20080270840 | DEVICE AND METHOD FOR TESTING EMBEDDED SOFTWARE USING EMULATOR - Embodiments of the invention provide a device and a method for automatically testing embedded software, and more specifically for testing interfaces between layers of the embedded software. In one embodiment, the device includes: an emulator; a server including embedded software; an evaluation board configured to download the embedded software from the server and controlled by the emulator; and a host system configured to receive the embedded software from the server and automatically generate test cases for testing the embedded software using the emulator. | 10-30-2008 |
20080268535 | Method for Inducing the Differentiation of Human Myelogenous Leukemia Cells Into Megakarocytes or Thrombocytes - Disclosed herein is a method of inducing the differentiation of leukemia cells derived from human bone marrow into megakaryocytes or thrombocytes, comprising the steps of: (a) culturing OP9 cells; (b) layering leukemia cells derived from human bone marrow over the OP9 cells; and (c) incubating the cells in the presence of a compound ((R)-NALPCE) represented by Chemical Formula 1. | 10-30-2008 |
20080256665 | Method for changing seed productivity of plant by controlling the level of AtSPF3 in plant - Disclosed is a method of changing the seed productivity of a plant by controlling the level of AtSPF3 in the plant. More specifically, disclosed is a method of changing the seed productivity of a plant by controlling the intracellular level of a polypeptide having the amino acid sequence represented by SEQ ID NO: 1. The AtSPF3 gene has the effect of changing the seed productivity of a plant through an increase or decrease in the expression thereof in the plant. Accordingly, the AtSPF3 gene will be useful for increasing the production of plants and breeding plants. | 10-16-2008 |
20080253929 | MICRO- OR NANO-FLUIDIC CHIP FABRICATED WITH NORLAND OPTICAL ADHESIVE AND BIOANALYSIS PLATFORM PRODUCED BY USING THE SAME - The present invention relates to a micro- or nano-fluidic chip fabricated with a NOA. Said micro- or nano-fluidic chip comprises sequentially an inlet, a channel, and an outlet, wherein the channel has pillar in the region of the outlet to prevent beads from flowing out. The surface of channels in the micro- or nano-fluidic chip of the invention is hydrophilc, which generates spontaneous flow in the channels by a capillary force without any extra external pumping. | 10-16-2008 |